Research
Hormonal
Regular physical activity, including both aerobic and resistance training, improves blood glucose control and insulin action in individuals with type 2 diabetes, with benefits lasting 2-72 hours post-exercise.
Aim for at least 150 minutes of moderate-to-vigorous aerobic exercise per week, spread over at least 3 days, with no more than 2 consecutive days of inactivity. Add resistance training 2-3 days per week. If you take insulin or certain medications, monitor your blood glucose and consult your doctor to adjust medication or carbohydrate intake to prevent hypoglycemia.
WeakSupportsHIGH confidence
Most benefits of PA on diabetes management and prevention are realized through acute and chronic improvements in insulin action... PA can result in acute improvements in systemic insulin action lasting from 2 to 72 h.
Why this rating
ACSM evidence category A (overwhelming data from RCTs) for several key statements.
Source
Exercise and Type 2 Diabetes
Sheri R. Colberg et al. · Diabetes Care · 2010
DOI 10.2337/dc10-9990
clinical_guidelineCited 1,930×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- High-intensity or intense aerobic exercise can cause transient hyperglycemia in individuals with Type 2 Diabetes, while moderate exercise generally lowers blood glucose.Moderate
- Supervised exercise training leads to greater improvements in blood glucose control and compliance compared to unsupervised training in individuals with Type 2 Diabetes.Limited
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →